VA Cooperative Study of the Efficacy of Hepatitis Immune Serum Globulin for the Prevention or Modification of Post-Transfusion Hepatitis (VA2-TAH-BioLINCC)
Getting access
No access information recorded yet.
About this database
| Last updated | 2026-08-25 |
|---|